About Us
Company Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Contact Us
Our Approach
The Opportunity in China
The Everest Advantage
Partners
Pipeline
Media
Investors
News
Search
05
2017/12
Arena eligible to receive up to $224M, including upfront and milestone payments, in addition to royalties.
27
2017/10
C-Bridge Capital specializes in the growing Chinese health care market and is using its expertise to identify emerging industry leaders and bring global innovation into China.
<<
<
1
2
3
4
5
6
7
8
9
>
>>
Copyright Everest Medicines 2020 云顶药业（苏州）有限公司
苏ICP备20038571号
|
Terms of Use
|
Privacy Policy
|
Disclaimers
沪公网安备 31010602006477号
